Newsletter | November 9, 2026

11.09.26 -- The Site Landscape Is Evolving, But How?

PATIENT RECRUITMENT

The Real Problem In Patient Recruitment… Is Knowing How And When To Use AI

AI might find patients faster, but only people earn their trust. A site COO explains how to pair AI speed with human judgment, plus the guardrails every site should build in.

Winning Enrollment In A Competitive CNS Trial Landscape

Explore how protocol screenability, site capacity, participant logistics, and recruitment handoffs affect enrollment momentum, along with early signals that can help teams spot where progress stalls.

Addressing The Singular Challenges Of Obesity Trials

Competition and complexity characterize the obesity trial environment, making patient recruitment doubly challenging. Starting early in the planning stage can help address any potential obstacles.

Finding The Solution(s) That Meet Patient, Site, And Sponsor Needs

Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.

CLINICAL SITES

The Site Landscape Is Evolving, But How? Tufts CSDD Shares New Findings

Tufts CSDD data reveals how academic, independent, and network-affiliated clinical trial sites differ in growth, reach, staffing, and performance.

Site Selection Solutions Using Patient Insights For Rare Disease Trials

Uncover recruitment opportunities and strengthen patient engagement with a data-driven approach to rare disease site selection, enrollment, and retention.

The Cost Of Caution In Clinical Trial Participant Support

Regulatory uncertainty around participant payments can create practical barriers to participation. Explore how clearer protections can support appropriate reimbursement while preserving safeguards.

The Real Reason Sites Haven't Digitized

Reducing site burden doesn’t require major change. Streamlining one workflow can boost efficiency, support compliance, and free staff to focus on patients.

Selecting A Central Lab Network For Radiopharmaceutical Readiness

A wave of late-stage radiopharmaceutical trials is straining lab infrastructure concentrated in a handful of academic centers, limiting site diversity, expertise, and trial capacity nationwide.

Transform Your Clinical Trials With Central eSource

Accelerate your trial startup and reduce site burden with a central eSource that allows sponsors to develop and publish central source templates to sites.

PATIENT CENTRICITY

Testing Early Treatment In Head And Neck Cancer Without Compromising Curative Care

Can early APG-157 treatment control head and neck cancer without delaying curative care? A Phase 3 trial puts timing, safety, and outcomes to the test.

Bringing Local Payments To International Clinical Trials

Replace slow international wires with local digital payments, reduce participant friction, and ensure fair, instant reimbursements across the globe.

Is An Overlooked Literacy Gap Stalling Clinical Trial Enrollment?

Here, we examine the critical disconnect in a patient's understanding and how purpose-built AI platforms can translate complex medical language into plain, accessible communication.

Connect With Clinical Leader: